Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Pharmacology|May 31, 2023
Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysisClément Mathieu, Julien Bezin, Antoine Pariente
American Journal of Hypertension|May 18, 2025
Effect of the COVID-19 epidemic on the association between antihypertensive drug interruption and the risk of major cardiovascular event in FranceClément Mathieu, Julien Bezin, Antoine Pariente
BDJ Open|March 28, 2026
A tool to measure the influence of social media on health behaviors: an exploratory studyChloé Rethaber, Clément Mathieu, Gabriel Fernandez de Grado, et al.
Scientific Reports|September 5, 2020
Impact of benzodiazepine consumption reduction on future burden of dementiaHélène Jacqmin-Gadda, Florian Guillet, Clément Mathieu, et al.
Drug Safety|October 30, 2020
Patterns of Benzodiazepine Use and Excess Risk of All-Cause Mortality in the Elderly: A Nationwide Cohort StudyClément Mathieu, Pierre Joly, Hélène Jacqmin-Gadda, et al.
British Journal of Clinical Pharmacology|February 22, 2026
Impact of secured prescription implementation on ambulatory pregabalin use in France: A regional assessment in the French Nouvelle-AquitaineMaika Munech-Herran, Véronique Moysan, Bruno Lescarret, et al.
European Journal of Epidemiology|September 21, 2022
Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort studyClément Mathieu, Elodie Pambrun, Anne Bénard-Laribière, et al.
Pharmacological Research|July 21, 2020
Risk of bradyarrhythmia related to ticagrelor: A systematic review and meta-analysisIris Pujade, Justine Perino, Clément Mathieu, et al.
Diabetes Care|November 10, 2022
GLP-1 Receptor Agonists and the Risk of Thyroid CancerJulien Bezin, Amandine Gouverneur, Marine Pénichon, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 25, 2024
Differential times of submission and approval of CFTR modulators for the treatment of Cystic Fibrosis in the United States and the European UnionEnrico Costa, Silvia Girotti, Clément Mathieu, et al.
Pageof 2